STK11 and adenocarcinoma: Liver kinase B1 (LKB1, also known as Serine/threonine kinase 11, STK11), responsible for maintenance of the balance between anabolic and catabolic processes, is mutated in about 30% of all adenocarcinoma and the co-mutation with KRAS is often reported [12–14].